Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dai One Food is a South Korean seafood company that appears to process and export oyster and other seafood products for commercial sale. Publicly available evidence indicates the company ships frozen oyster products into the U.S. market and has been identified in FDA safety alerts related to recalled oyster lots. Available sources point to Dai One Food being an operating food manufacturer/exporter rather than a life science, biotech, pharmaceutical, or healthcare company. No evidence was found of a therapeutic pipeline, drug development activities, or healthcare services. For biotech analyst purposes, this looks like a non-health commercial food business with seafood processing and export activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dai One Food.